HomePVCT • OTCMKTS
add
Provectus Biopharmaceuticals Inc
Previous close
$0.11
Day range
$0.11 - $0.11
Year range
$0.045 - $0.22
Market cap
49.05M USD
Avg Volume
282.15K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
WSJ
1 hour ago
Stock Market Today: Nasdaq, S&P 500 Fall; Nvidia, Macy's Stocks in Focus —
Live Updates
7.86%
2.69%
0.047%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 109.74K | 57.38% |
Operating expense | 460.26K | 24.31% |
Net income | -1.01M | -30.74% |
Net profit margin | -924.28 | 16.93% |
Earnings per share | — | — |
EBITDA | -753.65K | -17.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 187.46K | -48.96% |
Total assets | 802.03K | -52.55% |
Total liabilities | 6.22M | -32.41% |
Total equity | -5.42M | — |
Shares outstanding | 420.28M | — |
Price to book | -11.23 | — |
Return on assets | -227.89% | — |
Return on capital | 53.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.01M | -30.74% |
Cash from operations | -565.00K | 26.52% |
Cash from investing | — | — |
Cash from financing | 589.40K | -27.93% |
Net change in cash | 24.91K | -51.21% |
Free cash flow | -2.21M | -536.70% |
About
Founded
2002
Headquarters
Website
Employees
4
